List view / Grid view




Chemotherapy-free treatment for patients with blood cancer

8 June 2023 | By

Dr Andy Souers highlights the unwavering commitment to finding an enhanced therapeutic approach that eliminates the need for chemotherapy in blood cancer treatment. This transformative discovery represents a significant leap forward in the way we combat this complex disease, offering new hope to countless patients worldwide.


Lorenz Mayr joins Drug Discovery 2017 speaker lineup

31 January 2017 | By

Lorenz Mayr, esteemed Vice President and Global Head of Biological Reagents and Assay Development at AstraZeneca will be joining the expert speaker lineup for the launch conference on Drug Discovery. The event takes place on 27 and 28 April 2017 in London.


MD Anderson and AbbVie join forces to fight cancer

26 January 2016 | By Victoria White

The three-year collaboration agreement provides a framework for MD Anderson and AbbVie to efficiently choose and carry out preclinical and clinical studies evaluating new ideas in immuno-oncology...